Kelfred Holdings Limited
1134.HK
HKD0.325 67.53%
Exchange: HKSE | Sector: Healthcare | Industry: Medical Instruments Supplies
Q4 2024
Published: Dec 31, 2024

Earnings Highlights

  • Revenue of $128.08M up 29.3% year-over-year
  • EPS of $-0.01 decreased by 135% from previous year
  • Gross margin of 10.5%
  • Net income of -4.69M
  • "No transcript quotes available in the provided data." -

Kelfred Holdings Limited (1134.HK) QQ4 2024 Results – Revenue HKD 128.08m; Margin Pressure Yet Net Cash Strength Supports Strategic Growth

Executive Summary

Kelfred Holdings Limited posted QQ4 2024 revenue of HKD 128.084m, up 29.3% year-over-year, driven by stronger demand for eyewear products and OEM manufacturing activities. However, the quarter delivered a negative operating result of HKD -3.909m and a net loss of HKD -4.691m, underscoring ongoing investments and cost pressures that subdued profitability despite top-line growth. Gross margin stood at 10.49% (HKD 13.439m gross profit on revenue), reflecting a relatively modest profitability profile for a hardware-intensive eyewear producer in a competitive market. The company generated positive operating cash flow of HKD 7.886m and free cash flow of HKD 5.971m, supported by a cash balance of HKD 27.813m and a net debt position of HKD -15.252m. The balance sheet remains robust with total assets of HKD 282.928m, total liabilities of HKD 126.494m, and total equity of HKD 156.434m. Liquidity metrics are healthy (current ratio 2.04, quick ratio 1.31), while working capital movements (notably higher receivables and inventories) consumed cash during parts of the year. Notably, accumulated other comprehensive income stands sizable at HKD 151.434m, contributing meaningfully to equity and warranting further disclosure in follow-on filings. In the absence of formal earnings-call transcripts in the provided data, management commentary and forward-looking guidance could not be quoted or analyzed. Based on the quantitative results and prevailing industry dynamics, the investment thesis hinges on the ability to translate revenue growth into sustained profitability, tighter cost control, and capitalization on OEM/multibrand opportunities. Relative to peers, Kelfred demonstrates a stronger liquidity profile, but profitability remains a near-term hurdle that investors should monitor closely.

Key Performance Indicators

Revenue

128.08M
QoQ: 0.00% | YoY:29.25%

Gross Profit

13.44M
10.49% margin
QoQ: 0.00% | YoY:13.30%

Operating Income

-3.91M
QoQ: 0.00% | YoY:-100.93%

Net Income

-4.69M
QoQ: 0.00% | YoY:-135.67%

EPS

-0.01
QoQ: 0.00% | YoY:-135.00%

Revenue Trend

Margin Analysis

Key Insights

Revenue performance: HKD 128,084,499; YoY +29.25%; QoQ 0.00% Gross Profit: HKD 13,438,499; Gross Margin 10.49%; YoY +13.30%; QoQ 0.00% Operating Income: HKD -3,909,000; Operating Margin -3.05%; YoY -100.93%; QoQ 0.00% Net Income: HKD -4,691,000; Net Margin -3.66%; YoY -135.67%; QoQ 0.00% Earnings Per Share (EPS): HKD -0.0094; YoY -135.00%; QoQ 0.00% Cash Flow: Operating Cash Flow HKD 7,886,000; Free Cash Flow HKD 5,971,500; Capex HKD -1,914,500 Liquidity & Balance Sheet: Cash and cash equiva...

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q2 2025 242.52 -0.01 +89.4% View
Q1 2025 121.26 0.00 +22.9% View
Q4 2024 128.08 -0.01 +29.3% View
Q3 2024 128.08 -0.01 +29.3% View